Noggin haploinsufficiency differentially affects tissue responses in destructive and remodeling arthritis

Arthritis and Rheumatism

Volumn 54, Issue 6, 2006, Pages 1736-1746

  Lories, Rik J U ^a   Daans, Melina ^a   Derese, Inge ^a   Matthys, Patrick ^b   Kasran, Ahmad ^a   Tylzanowski, Przemko ^a   Ceuppens, Jan L ^a   Luyten, Frank P ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BOVINE SERUM ALBUMIN; CD4 ANTIGEN; COLLAGEN; GLYCOSAMINOGLYCAN; NOGGIN; SAFRANIN O SULFATED GLYCOSAMINOGLYCAN; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKYLOSIS; ARTICLE; CARTILAGE DEGENERATION; CONTROLLED STUDY; DIGITAL IMAGING; DISEASE COURSE; DISEASE MODEL; GENE TRANSFER; HETEROZYGOTE; HOMEOSTASIS; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MONARTHRITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; ARTHRITIS, EXPERIMENTAL; BONE MORPHOGENETIC PROTEINS; CARRIER PROTEINS; CARTILAGE, ARTICULAR; DISEASE PROGRESSION; GENE TRANSFER TECHNIQUES; HOMEOSTASIS; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; OSTEOGENESIS; SERUM ALBUMIN, BOVINE; SIGNAL TRANSDUCTION;

EID: 33745013841     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21897     Document Type: Article

References (50)

1. Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet 2001;358:903-11.
2. Wright V. Seronegative polyarthritis: a unified concept. Arthritis Rheum 1978;21:619-33.
3. Khan MA. Update on spondyloarthropathies. Ann Intern Med 2002;136:896-907.
4. Ball J. Enthesopathy of rheumatoid and ankylosing spondylitis. Ann Rheum Dis 1971;30:213-23.
5. Benjamin M, McGonagle D. The anatomical basis for disease localisation in seronegative spondyloarthropathy at entheses and related sites. J Anat 2001;199:503-26.
6. McGonagle D, Gibbon W, O'Connor P, Green M, Pease C, Emery P. Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondylarthropathy. Arthritis Rheum 1998;41:694-700.
7. Pelletier JP, Martel-Pelletier J, Abramson SB. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum 2001;44:1237-47.
8. Lories RJ, Luyten FP. Bone morphogenetic protein signaling in joint homeostasis and disease. Cytokine Growth Factor Rev 2005;16:287-98.
9. Urist MR. Bone: formation by autoinduction. Science 1965;150:893-9.
10. Olsen BR, Reginato AM, Wang WF. Bone development. Annu Rev Cell Dev Biol 2000;16:191-220.
11. Kronenberg HM. Developmental regulation of the growth plate. Nature 2003;423:332-6.
12. Reddi AH. Cartilage morphogenetic proteins: role in joint development, homeostasis, and regeneration. Ann Rheum Dis 2003;62:73-8.
13. Storm EE, Huynh TV, Copeland NG, Jenkins NA, Kingsley DM, Lee SJ. Limb alterations in brachypodism mice due to mutations in a new member of the TGF β-superfamily. Nature 1994;368:639-43.
14. Thomas JT, Lin K, Nandedkar M, Camargo M, Cervenka J, Luyten FP. A human chondrodysplasia due to a mutation in a TGF-β superfamily member. Nat Genet 1996;12:315-7.
15. Thomas JT, Kilpatrick MW, Lin K, Erlacher L, Lembessis P, Costa T, et al. Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1. Nat Genet 1997;17:58-64.
16. Polinkovsky A, Robin NH, Thomas JT, Irons M, Lynn A, Goodman FR, et al. Mutations in CDMP1 cause autosomal dominant brachydactyly type C. Nat Genet 1997;17:18-9.
17. Massague J. How cells read TGF-β signals. Nat Rev Mol Cell Biol 2000;1:169-78.
18. Waite KA, Eng C. From developmental disorder to heritable cancer: it's all in the BMP/TGF-β family. Nat Rev Genet 2003;4:763-73.
19. Lories RJ, Derese I, Luyten FP. Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. J Clin Invest 2005;115:1571-9.
20. Matthys P, Dillen C, Proost P, Heremans H, van Damme J, Billiau A. Modification of the anti-CD3-induced cytokine release syndrome by anti-interferon-γ or anti-interleukin-6 antibody treatment: protective effects and biphasic changes in blood cytokine levels. Eur J Immunol 1993;23:2209-16.
21. Lawlor KE, Campbell IK, O'Donnell K, Wu L, Wicks IP. Molecular and cellular mediators of interleukin-1-dependent acute inflammatory arthritis. Arthritis Rheum 2001;44:442-50.
22. Corthay A, Hansson AS, Holmdahl R. T lymphocytes are not required for the spontaneous development of entheseal ossification leading to marginal ankylosis in the DBA/1 mouse. Arthritis Rheum 2000;43:844-51.
23. Matthys P, Lories RJ, De Klerck B, Heremans H, Luyten FP, Billiau A. Dependence on interferon-γ for the spontaneous occurrence of arthritis in DBA/1 mice. Arthritis Rheum 2003;48:2983-8.
24. Lories RJ, Matthys P, Derese I, De Vlam K, Luyten FP. Ankylosing enthesitis, dactylitis and onychoperiostitis in a mouse model of psoriatic arthritis. Ann Rheum Dis 2004;63:595-8.
25. Vermeire K, Heremans H, Vandeputte M, Huang S, Billiau A, Matthys P. Accelerated collagen-induced arthritis in IFN-γ receptor deficient mice. J Immunol 1997;158:5507-13.
26. Backlund J, Nandakumar KS, Bockermann R, Mori L, Holmdahl R. Genetic control of tolerance to type II collagen and development of arthritis in an autologous collagen-induced arthritis model. J Immunol 2003;171:3493-9.
27. Tardif G, Hum D, Pelletier JP, Boileau C, Ranger P, Martel-Pelletier J. Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts. Arthritis Rheum 2004;50:2521-30.
28. Semevolos SA, Nixon AJ, Strassheim ML. Expression of bone morphogenetic protein-6 and -2 and a bone morphogenetic protein antagonist in horses with naturally acquired osteochondrosis. Am J Vet Res 2004;65:110-5.
29. Chen AL, Fang C, Liu C, Leslie MP, Chang E, Di Cesare PE. Expression of bone morphogenetic proteins, receptors, and tissue inhibitors in human fetal, adult, and osteoarthritic articular cartilage. J Orthop Res 2004;22:1188-92.
30. Brunet LJ, McMahon JA, McMahon AP, Harland RM. Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science 1998;280:1455-7.
31. Simic P, Vukicevic S. Bone morphogenetic proteins in development and homeostasis of kidney. Cytokine Growth Factor Rev 2005;16:299-308.
32. Lin J, Patel SR, Cheng X, Cho EA, Levitan I, Ullenbruch M, et al. Kielin/chordin-like protein, a novel enhancer of BMP signaling, attenuates renal fibrotic disease. Nat Med 2005;11:387-93.
33. Marie I, Poljak L, Zoricic S, Bobinac D, Bosukonda D, Sampath KT, et al. Bone morphogenetic protein-7 reduces the severity of colon tissue damage and accelerates the healing of inflammatory bowel disease in rats. J Cell Physiol 2003;196:258-64.
34. He XC, Zhang J, Tong WG, Tawfik O, Ross J, Scoville DH, et al. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-β-catenin signaling. Nat Genet 2004;36:1117-21.
35. Dell'Accio F, De Bari C, Luyten FP. Molecular markers predictive of the capacity of expanded human articular chondrocytes to form stable cartilage in vivo. Arthritis Rheum 2001;44:1608-19.
36. Chubinskaya S, Merrihew C, Cs-Szabo G, Mollenhauer J, McCartney J, Rueger DC, et al. Human articular chondrocytes express osteogenic protein-1. J Histochem Cytochem 2000;48:239-50.
37. Muehleman C, Kuettner KE, Rueger DC, ten Dijke P, Chubinskaya S. Immunohistochemical localization of osteogenetic protein (OP-1) and its receptors in rabbit articular cartilage. J Histochem Cytochem 2002;50:1341-50.
38. Chubinskaya S, Kumar B, Merrihew C, Heretis K, Rueger DC, Kuettner KR. Age-related changes in cartilage endogenous osteogenic protein-1 (OP-1). Biochim Biophys Acta 2002;1588:126-34.
39. Erlacher L, Ng CK, Ullrich R, Krieger S, Luyten FP. Presence of cartilage-derived morphogenetic proteins in articular cartilage and enhancement of matrix replacement in vitro. Arthritis Rheum 1998;41:263-73.
40. Bobacz K, Gruber R, Soleiman A, Graninger WB, Luyten FP, Erlacher L. Cartilage-derived morphogenetic protein-1 and -2 are endogenously expressed in healthy and osteoarthritic human articular chondrocytes and stimulate matrix synthesis. Osteoarthritis Cartilage 2002;10:394-401.
41. Rountree RB, Schoor M, Chen H, Marks ME, Harley V, Mishina Y, et al. BMP receptor signaling is required for postnatal maintenance of articular cartilage. PLoS Biol 2004;2:e355.
42. Van Beuningen HM, Glansbeek HL, van der Kraan PM, van Den Berg WB. Differential effects of local application of BMP-2 or TGF-β 1 on both articular cartilage composition and osteophyte formation. Osteoarthritis Cartilage 1998;6:306-17.
43. Scharstuhl A, Vitters EL, van der Kraan PM, van den Berg WB. Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor β/bone morphogenetic protein inhibitors during experimental osteoarthritis. Arthritis Rheum 2003;48:3442-51.
44. Pizette S, Niswander L. BMPs are required at two steps of limb chondrogenesis: formation of prechondrogenic condensations and their differentiation into chondrocytes. Dev Biol 2000;219:237-49.
45. Minina E, Wenzel HM, Kreschel C, Karp S, Gaffield W, McMahon AP, et al. BMP and Ihh/PTHrP signaling interact to coordinate chondrocyte proliferation and differentiation. Development 2001;128:4523-34.
46. Seto H, Kamekura S, Miura T, Yamamoto A, Chikuda H, Ogata T, et al. Distinct roles of Smad pathways and p38 pathways in cartilage-specific gene expression in synovial fibroblasts. J Clin Invest 2004;113:718-26.
47. Bleul CC, Boehm T. BMP signaling is required for normal thymus development. J Immunol 2005;175:5213-21.
48. Bhatia M, Bonnet D, Wu D, Murdoch B, Wrana J, Gallacher L, et al. Bone morphogenetic proteins regulate the developmental program of human hematopoietic stem cells. J Exp Med 1999;189:1139-48.
49. Graf D, Nethisinghe S, Palmer DB, Fisher AG, Merkenschlager M. The developmentally regulated expression of Twisted gastrulation reveals a role for bone morphogenetic proteins in the control of T cell development. J Exp Med 2002;196:163-71.
50. Hager-Theodorides AL, Outram SV, Shah DK, Sacedon R, Shrimpton RE, Vicente A, et al. Bone morphogenetic protein 2/4 signaling regulates early thymocyte differentiation. J Immunol 2002;169:5496-504.